Show simple item record

FieldValueLanguage
dc.contributor.authorBarnwi, Faisal Ali E.
dc.date.accessioned2019-10-02
dc.date.available2019-10-02
dc.date.issued2018-07-09
dc.identifier.urihttp://hdl.handle.net/2123/21169
dc.description.abstractMultiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). MS is characterized by demyelinating lesions that occur in different regions of the CNS at different times. The cause of the inflammatory lesion in MS remains uncertain and the antigenic targets are unknown. Although antibodies specific for immune proteins expressed in myelin, axons and the nodes of Ranvier have been shown to occur in MS and may be salient to the disease process, none have yet been consistently associated with the pathogenesis of the disease. Given that the principal correlate of brain atrophy in pathology studies of MS is the loss of neurons and that brain atrophy correlates with clinical outcomes, this study was designed to determine whether neuronal antibodies are found in MS and whether they are associated with clinical outcome measures and disease phenotypes. Serum from 79 patients with MS, 60 patients with other inflammatory neurological disease (OIND), 15 non-inflammatory neurological controls (OND) and 61 healthy blood donors were analysed using indirect immunofluorescence on rat brain and spinal cord tissues. High titre neuronal antibodies were more prevalent in MS patients (19%) than OIND (16.7%, OND (0%) and healthy controls (6.6%). Neuronal antibodies in MS were identified against the cell soma, cell cytostructure, dendrites and synapses and the neuropil. The most frequently identified antibody in MS was directed against interneurons. Neuronal antibodies in MS did not correlate with disease duration or disability scores. However, neuronal antibodies were only found in cerebral-predominant (rather than spinal predominant) forms of MS and were not detected in the similar but distinct demyelinating disease, Neuromyelitis Optica. Taken together these findings imply that whilst neuronal antibodies are not specific for MS, they may have a role in inflammatory progression of the disease, in contradistinction to NMO which is very rarely progressive in form.en_AU
dc.publisherUniversity of Sydneyen_AU
dc.publisherFaculty of Medicine and Healthen_AU
dc.publisherCentral Clinical Schoolen_AU
dc.rightsThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
dc.subjectMultiple Sclerosisen_AU
dc.subjectNeuronal Antibodiesen_AU
dc.titleSerum Anti-Neuronal Antibodies in Multiple Sclerosisen_AU
dc.typeMasters Thesisen_AU
dc.type.pubtypeMaster of Philosophy M.Philen_AU
dc.description.disclaimerAccess is restricted to staff and students of the University of Sydney . UniKey credentials are required. Non university access may be obtained by visiting the University of Sydney Library.en_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.